Sinovac to reach two billion vaccine doses annually
BEIJING – China’s Sinovac Biotech conformed its third production plant for its COVID-19 vaccine was ready and had started manufacturing procedures for bulk vaccine ingredient, doubling its annual capacity to 2 billion doses. A Sinovac spokesman said the third facility, … Continue reading Sinovac to reach two billion vaccine doses annually
CureVac: Over 100 Million vaccines to be produced
TÜBINGEN – CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) and Celonic Group, a premium biopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in the development and production … Continue reading CureVac: Over 100 Million vaccines to be produced
EMA Approves BioNTech Storage Option for EU
NEW YORK/MAINZ – Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Medicines Agency (EMA) approved storage of COMIRNATY® at -25°C to -15°C for a total of two weeks based on data showing the stability at these temperatures in … Continue reading EMA Approves BioNTech Storage Option for EU
Moderna vaccine approved by Singapore Health Authority
CAMBRIDGE, Mass./Singapore -Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Singapore Health Sciences Authority (HSA) has approved the interim authorization of its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use … Continue reading Moderna vaccine approved by Singapore Health Authority
Moderna: Provides 600 million dosis of vaccine
CAMBRIDGE, Mass – Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global production estimate from 500 to 600 million doses for 2021. Moderna said it … Continue reading Moderna: Provides 600 million dosis of vaccine